Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumab
Wataru Fukuokaya(Jikei University School of Medicine), Shin Egawa, Jun Miki(Jikei University School of Medicine), Yuhei Koike(Jikei University School of Medicine), Yuki Enei(Jikei University School of Medicine), Takafumi Yanagisawa(Jikei University School of Medicine), Mariko Honda(Jikei University School of Medicine), Masatoshi Tanaka(Fukushima Medical University), Shunsuke Tsuzuki(Jikei University School of Medicine), Takahiro Kimura(Jikei University School of Medicine), Yuya Iwamoto(Jikei University School of Medicine), Hirokazu Abe(Kameda Medical Center), Yu Oyama(Kameda Medical Center), Shoji Kimura(Jikei University School of Medicine), Hajime Onuma(Jikei University School of Medicine), Fumihiko Urabe(Jikei University School of Medicine)
Cited by 6
Related Papers
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
Phosphorus flame retardants in indoor dust and their relation to asthma and allergies of inhabitants
|Indoor Air|2013|221
Exposure to house dust phthalates in relation to asthma and allergies in both children and adults
|The Science of The Total Environment|2014|158